Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03397186
Title Immune Changes Following Trabectedin in Patients With Metastatic or Unresectable Sarcoma
Recruitment Withdrawn
Gender both
Phase Phase II
Variant Requirements No
Sponsors Fred Hutchinson Cancer Research Center
Indications

sarcoma

Therapies

Trabectedin

Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Fred Hutch/University of Washington Cancer Consortium Seattle Washington 98109 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field